Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
Sales | 22,733 | 26,279 | 27,655 | 27,448 | 24,199 |
Cost of Goods | 9,990 | 8,986 | 9,623 | 12,606 | 11,513 |
Gross Profit | 12,743 | 17,293 | 18,032 | 14,842 | 12,686 |
Operating Expenses | 22,291 | 25,147 | 20,463 | 32,940 | 66,620 |
Operating Income | -8,558 | -6,868 | -1,808 | -17,492 | -53,421 |
Other Income | 1,358 | 175 | 1,107 | 1,403 | 130 |
Pre-tax Income | -7,200 | -6,693 | -701 | -16,089 | -53,291 |
Net Income Continuous | -7,200 | -6,693 | -701 | -16,089 | -53,291 |
Net Income | $-7,200 | $-6,693 | $-701 | $-16,089 | $-53,291 |
EPS Basic Total Ops | -1.93 | -2.15 | -0.28 | -7.61 | -35.90 |
EPS Basic Continuous Ops | -1.93 | -2.15 | -0.28 | -7.59 | -35.91 |
EPS Diluted Total Ops | -1.93 | -2.15 | -0.28 | -7.61 | -35.90 |
EPS Diluted Continuous Ops | -1.93 | -2.15 | -0.28 | -7.59 | -35.91 |
EPS Diluted Before Non-Recurring Items | -1.93 | -1.31 | -1.20 | -5.00 | N/A |
EBITDA(a) | $-8,868 | $-1,892 | $638 | $-4,321 | $-5,593 |